Stinging Nettle for Health & Longevity - Quick Reference Sheet

Stinging Nettle for Health & Longevity

Created on 10/13/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Wonder 1.0 – Audit

Stinging nettle is a flowering plant used as a cooked green, tea, and dried leaf or root preparation. Root preparations have suggestive evidence for urinary symptoms linked to prostate enlargement, while leaf preparations may lower fasting blood sugar; seasonal allergy evidence is very limited. Effects beyond these uses rest mainly on laboratory work, and dried or cooked forms appear to have modest harms in trials. (Full Review)

Protocol

Root extract for prostate symptoms
360 mg aqueous root extract daily
In three divided doses over six months
Leaf extract capsules
500 mg leaf extract every eight hours
For three months alongside oral diabetes medication
Freeze-dried leaf for allergy
600 mg dried leaf daily
In three divided doses for one week during allergy symptoms
Time to effect
Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia
6 months
Root extract trial assessment
Glycemic Control in Type 2 Diabetes
3 months
Leaf extract trial assessment
Allergic Rhinitis Symptoms
1 week
Freeze-dried leaf trial assessment

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Known allergy to stinging nettle or related plants
  • Children
Key Interactions
  • Glucose-lowering medication (for example metformin, insulin)
  • Blood pressure-lowering medication (for example lisinopril, amlodipine)
  • Diuretics (for example furosemide, hydrochlorothiazide)
  • Lithium
  • Sedative or allergy medication (for example diphenhydramine)
  • Anticoagulants (for example warfarin)
  • Other supplements lowering glucose or pressure (berberine, hibiscus)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Skin sting and contact reaction from fresh plant
  • Low: Gastrointestinal upset; Breast changes
  • Speculative: Additive blood sugar lowering; Additive blood pressure lowering; Uterine or hormonal effects

Monitoring

Marker Target Why
Fasting glucose 70–99 mg/dL (standard reference range) Marker the intervention is expected to change
Glycated hemoglobin No established target — track change from the individual's own baseline Marker the intervention is expected to change
Systolic blood pressure No established target — track change from the individual's own baseline Marker the intervention is expected to change and safety check
Creatinine 0.6–1.3 mg/dL (standard reference range) Safety check
Estimated glomerular filtration rate No established target — track change from the individual's own baseline Safety check
Prostate-specific antigen No established target — track change from the individual's own baseline Safety check in prostate use

Cadence: Baseline assessment before starting; ongoing monitoring at four to eight weeks, then every three to six months

Qualitative Assessment

  • Urinary symptom score: Tracks day-to-day voiding difficulty, frequency, and night-time urination.
  • Allergy symptom diary: Tracks sneezing, congestion, and itching during exposure periods.
  • Energy and joint comfort: Tracks perceived stamina and thumb or joint pain during activity.
  • Sleep and tolerance notes: Tracks sleep quality, gastrointestinal upset, rash, or dizziness after starting.